Corteva (NYSE:CTVA) Given New $10.30 Price Target at Citigroup

Corteva (NYSE:CTVA) had its target price reduced by stock analysts at Citigroup from $13.65 to $10.30 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup‘s price target suggests a potential upside of 9.40% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. New Street Research set a $17.00 price target on shares of Corteva in a report on Monday, October 5th. Deutsche Bank restated a “buy” rating and issued a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. UBS Group lowered their target price on Corteva from $15.00 to $10.00 and set a “neutral” rating for the company in a research report on Friday. Weiss Ratings downgraded Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $20.00 target price on shares of Corteva in a report on Thursday, October 8th. Fifteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $52.60.

Corteva Trading Up 2.4%

CTVA traded up $0.23 during trading on Friday, reaching $9.41. 27,975,143 shares of the company’s stock were exchanged, compared to its average volume of 8,337,318. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a one year low of $9.01 and a one year high of $90.97. The firm has a fifty day moving average price of $38.81 and a two-hundred day moving average price of $69.88. The stock has a market capitalization of $6.28 billion, a PE ratio of 6.24, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58.

Hedge Funds Weigh In On Corteva

Hedge funds have recently bought and sold shares of the company. BlackRock Inc. bought a new position in shares of Corteva in the 2nd quarter worth about $4,560,180,000. Wellington Management Group LLP lifted its stake in shares of Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the period. Royal Bank of Canada boosted its position in shares of Corteva by 202.1% during the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock valued at $624,362,000 after purchasing an additional 4,989,371 shares in the last quarter. Jupiter Topco LLC bought a new stake in shares of Corteva during the 2nd quarter valued at about $544,246,000. Finally, Bank of America Corp DE acquired a new stake in Corteva during the second quarter worth approximately $484,927,000. Institutional investors own 81.54% of the company’s stock.

Corteva News Summary

These are some of the CTVA news items that stood out recently:

• Neutral Sentiment: JPMorgan cut its price target to $16 but kept an Overweight rating; RBC lowered its target to $11 while retaining Outperform. UBS cut its target to $10 and maintained Neutral, reflecting a more cautious view. JPMorgan analyst ratings
• Negative Sentiment: Brazilian inventory overhang and pricing pressure weighed on results, and management lowered 2026 adjusted EPS guidance to $0.76–$0.80 from a consensus estimate of $1.07. Revenue also fell 8.7% year over year, adding to investor concern about the duration of the downturn. Reuters: Corteva shares slide after Brazil weakness prompts forecast cut
• Negative Sentiment: A law firm announced an investigation into possible securities-law violations related to Corteva. The announcement is an allegation, not a finding, but may add reputational and legal uncertainty. Securities investigation announcement

About Corteva

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.